BANK OF AMERICA CORP /DE/ - ASLAN PHARMACEUTICALS LTD ownership

ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 35 filers reported holding ASLAN PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ASLAN PHARMACEUTICALS LTD
ValueSharesWeighting
Q2 2022$44,000
-81.1%
88,146
-66.1%
0.00%
Q1 2022$233,000
+7.9%
259,722
+34.4%
0.00%
Q4 2021$216,000
+7100.0%
193,178
+22573.5%
0.00%
Q1 2021$3,000
-98.2%
852
-98.9%
0.00%
Q4 2019$164,00080,7770.00%
Other shareholders
ASLAN PHARMACEUTICALS LTD shareholders Q4 2021
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 1,498,192$1,678,0000.68%
TANG CAPITAL MANAGEMENT LLC 2,054,925$2,302,0000.46%
Sio Capital Management, LLC 1,270,758$1,423,0000.43%
DAFNA Capital Management LLC 732,500$820,0000.21%
Vivo Capital, LLC 2,840,909$3,182,0000.19%
MANGROVE PARTNERS IM, LLC 2,514,576$2,816,0000.17%
SABBY MANAGEMENT, LLC 899,850$1,008,0000.15%
Waterfront Wealth Inc. 270,000$302,0000.12%
Knott David M Jr 230,251$258,0000.09%
RTW INVESTMENTS, LP 3,250,000$3,640,0000.05%
View complete list of ASLAN PHARMACEUTICALS LTD shareholders